The Cancer Biology & Therapeutics Program aims to integrate various basic research activities, platform technologies and pre-clinical model systems available within Peter Mac to discover, develop, characterise and refine novel cancer therapeutics for clinical use for solid tumours...

The Cancer Evolution & Metastasis Program focuses on understanding the mechanisms of cancer initiation, progression and metastatic spread...

Harnessing the power of the immune system to fight cancer through research into cancer immune surveillance and chemo/immunotherapy, defining key cells and molecules that can elicit an effective response to tumours.

The Computational Biology Program uses mathematics, statistics and computing to generate new discoveries in cancer. We develop new models, algorithms and software tools, and apply these to make sense of cancer data. This includes whole genome, exome, transcriptome and epigenome sequencing data.

The primary focus of the Organogenesis & Cancer Program is to investigate the process of organ development and how failure of organogenesis contributes to cancer...

Peter Mac is committed to linking patient care with cancer research. Our clinician researchers take their observations from the clinic and plan their research directions with patients in mind.